Skip to main content

How can we help you?

Sybren de Beurs Partner

Sybren de Beurs is a partner at the Corporate M&A practice of NautaDutilh's Amsterdam office. He focusses his practice primarily on public and private cross-border deals and venture capital funding and has a sector specific focus on the tech and life sciences industry. Sybren develops multifaceted bespoke solutions to client challenges by leveraging a wide breadth of experience in M&A, a pragmatic approach and a solid business sense.

Sybren has been involved in assisting:
 

  • Mylan's USD 22 bn merger with Pfizer division Upjohn
  • NASDAQ on its auction sale of BWise
  • Arvelle Therapeutics Series A financing up to USD and inlicensing from SK Biopharmaceuticals with an upfront payment of USD 100 million with a future milestone potential of up to USD 430
  • Binck Bank on Saxo Bank's recommended public offer
  • Docdata on the disposal of its entire business by a coordinated simultaneous sale of both its businesses valued around EUR 200 million
  • Incyte on its EUR 300 million PIPE transaction and collaboration agreement with Merus
  • FairPhone as company counsel and on its Series C financing of around EUR 20 million
  • Siemens Healthineers on its strategical Series A investment in Screenpoint Medical
  • J&J Innovation on its investment in Biogeneration Ventures Fund
  • VarmX on its Series A investment round
  • Groupe Casino on the spin-off of Cnova's Brazilian ecommerce business towards its JV partner Via Varejo and related exit offer to Cnova's minority shareholders
  • Blackline on its USD 31 million acquisition of Runbook
     

Cookie notice

Our website only uses cookies when you play video content. Video content is streamed from Vimeo. Our website does not use tracking cookies and/or third party cookies when you do not play video content. Please read the privacy/cookie policy for more information.